Immo Pharma Pas
ActiveImmo Pharma Pas has been active since 1991 and the Belgian State Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €193k and a net result of €-15k. Equity remains stable across the filed fiscal years (±1.8% per year). Its solvency ranks better than 93% of 101 sector peers (fiscal year 2026). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2026
76
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2025
Profitability10▼-9
Solvency100=
Growth52=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €14k at 30 days acceptable
Liquidity ample (current ratio 16.74; short-term debt: 5.6% and cash: 77.2% of total assets), and 5.6% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 70
Relative position
BE, all sectors
reference
Sector 70
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Persistent losses
Two consecutive loss-making years (2025 and 2026); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2026Net result per financial year
1920212223242526
2019 to 2026 · latest year €-15k
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2026 was due by 31-10-2026 and was filed on 02-09-2026, 59 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2026
59 d early
2025
25 d early
2024
106 d early
2023
35 d early
2022
39 d early
2021
100 d early
2020
93 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-03-2027 and is due by 31-10-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
19-09-2026 today31-03-2027 close31-10-2027 deadline
Financials · fiscal year 2026, abbreviated schema
Equity
€193k▼ 20.5%
2025 · €242k
2019: €168k
2020: €193k
2021: €305k
2022: €318k
2023: €287k
2024: €255k
2025: €242k
2019 → 2026
Total assets
€204k▼ 16.0%
2025 · €243k
2019: €307k
2020: €313k
2021: €358k
2022: €349k
2023: €314k
2024: €282k
2025: €243k
2019 → 2026
Net result
€-15k▼ 13.2%
2025 · €-13k
2019: €10k
2020: €24k
2021: €112k
2022: €13k
2023: €7k
2024: €-4k
2025: €-13k
2019 → 2026
Working capital
€181k▼ 17.0%
2025 · €218k
2019: €-109k
2020: €169k
2021: €309k
2022: €257k
2023: €237k
2024: €218k
2025: €218k
2019 → 2026
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20222023202420252026Trend
Equity€318k-€287k▼ 9.5%€255k▼ 11.2%€242k▼ 5.1%€193k▼ 20.5%
Operating result€19k-€12k▼ 36.7%€4k▼ 63.8%€-12k€-14k▼ 14.5%
Net result€13k-€7k▼ 44.6%€-4k€-13k▼ 195%€-15k▼ 13.2%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €14k in 2026 against €12k in 2025; the loss grows and 2026 has the lowest result in the available series.
Balance-sheet composition
2026 in colour, 2025 as the grey bar beneath
Assets €204k
Fixed assets
€12k▼ 51.8%
Current assets
€192k▼ 12.0%
Equity and liabilities €204k
Equity
€193k▼ 20.5%
Debt
€11k▲ 1,278%
The debt ratio rises from 0.3% to 5.6%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€-1k▼
2025 · €398
Cash flow
€-2k▼
2025 · €-310
Solvency
94.4%▼
2025 · 99.7%
Current ratio
16.74
Quick ratio
16.74
Debt / equity
0.06▲
2025 · 0.00
ROE
-7.6%▼
2025 · -5.4%
ROA
-7.2%▼
2025 · -5.4%
Interest coverage
-3.17▼
2025 · 0.81
Debt
€11k▲
2025 · €833
Debt ≤ 1 year
€11k▲
2025 · €833
Income taxes
€201▼
2025 · €220
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2026 against 2025
Balance sheet
Code20252026
Assets
Total assets20/58€243k€204k▼
Fixed assets21/28€25k€12k▼
Tangible fixed assets22/27€25k€12k▼
Plant, machinery and equipment23€788€390▼
Furniture and vehicles24€24k€11k▼
Current assets29/58€218k€192k▼
Amounts receivable within one year40/41€30k€31k▲
Trade receivables40€1k€1k▲
Other amounts receivable41€29k€29k▲
Cash at bank and in hand54/58€187k€157k▼
Deferred charges and accrued income490/1€675€4k▲
Equity and liabilities
Total equity and liabilities10/49€243k€204k▼
Equity10/15€242k€193k▼
Contributions10/11€62k€62k=
Capital10€62k€62k=
Issued capital100€62k€62k=
Reserves13€198k€163k▼
Non-distributable reserves130/1€6k€6k=
Legal reserve130€6k€6k=
Distributable reserves133€191k€156k▼
Profit (loss) carried forward14€-17k€-32k▼
Amounts payable17/49€833€11k▲
Amounts payable within one year42/48€833€11k▲
Trade debts44€26€4k▲
Suppliers440/4€26€4k▲
Taxes, remuneration and social security45€788€201▼
Taxes450/3€788€201▼
Other amounts payable47/48€19€7k▲
Income statement
Code20252026
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€13k€13k=
Other operating charges640/8€505€520▲
Gross operating margin9900€903€-868▼
Operating profit (loss)9901€-12k€-14k▼
Financial income75/76B-€0
Recurring financial income75-€0
Financial charges65/66B€488€438▼
Recurring financial charges65€488€438▼
Profit (loss) for the period before taxes9903€-13k€-15k▼
Income taxes67/77€220€201▼
Profit (loss) for the period9904€-13k€-15k▼
Profit (loss) for the period to be appropriated9905€-13k€-15k▼
Appropriation of the result
Profit (loss) to be appropriated9906€-17k€-32k▼
Profit (loss) brought forward from the previous period14P€-4k€-17k▼
Transfer from equity791/2€0€35k▲
Profit to be distributed694/7€0€35k▲
Return on contributions (dividend)694€0€35k▲
The notes to these accounts (3 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2027, expected by
2026
02-09
NBB filing
Annual accounts filed
fiscal year 2026 · abbreviated schema
31-03
Financial
Weakest financial yearnet €-15k
Net result drops to €-15k, the lowest in the series.
2025
06-10
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
31-03
Financial
Liquidity times 29current ratio 262.22
Current ratio from 9.20 to 262.22; short-term debt falls from €27k to €833.
2024
17-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2023
26-09
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2022
22-09
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2021
23-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
31-03
Financial
Highest result since 2019net €112k ▲360%
Operating result €162k, net result €112k, both a record.
31-03
Financial
Liquidity triplescurrent ratio 7.25
Current ratio from 2.52 to 7.25; short-term debt falls from €111k to €49k.
31-03
Financial
Equity above €200kEq €305k ▲58.2%
3 profitable years in a row build equity to €305k.
2020
30-07
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
31-03
Financial
Liquidity times 18current ratio 2.52
Current ratio from 0.14 to 2.52; short-term debt falls from €127k to €111k.
2019
11-07
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2018
25-06
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2017
11-07
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
6 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Kasterlee · 1 establishment unit since 1991
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Mezenstraat 22460 KasterleeGround area
1,623 m²
Building footprint
184 m²
Volume, LiDAR
1,129 m³
Parcel 13018D0221/00P005, Flanders · tallest building 9.1 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Mezenstraat 2, 2460 Kasterlee
since 19912.052.291.455
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 13018D0221/00P005 | Flanders | 1,623 m² | 1 · 184 m² | 9.1 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
BRAEMS PHARMA CONSULTING
BE 0719.866.791
Villers-la-Ville · Eq €193k
ErnestSong
BE 0797.328.914
Brussel · Eq €193k
Philip Laheij
BE 0841.590.113
Hove · Eq €193k
MBL MANAGEMENT
BE 0643.718.031
Brussel · Eq €193k
ALPHA CONSULTING
BE 0438.834.037
Sint-Genesius-Rode · Eq €192k
Of 82,570 companies in sector 70200 we hold annual accounts for 52,568. 40,159 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPublic limited company
Founded26-03-1991
Fiscal year end31-03
Activities, NACEBEL
70200Business and other management consultancy
70220Business consulting
74142
Sources
Crossroads Bank for EnterprisesNational Bank · 35 filingsAddress and cadastre registers
Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.